Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Lilly hopes $1bn platform leads to new medicines
“Turning point in how we treat EGFR-mutated lung cancer”
Positive results from chronic gout trial
Pfizer and BioNTech say robust immune response with COVID-19 vaccine
Regeneron advances allergy pipeline to combat cat and birch allergies
Telomere protection and the fight against cancer
Antibiotic-free bacterial vaginosis treatment receives CE-marking
Lilly obesity drug success in third phase 3 trial